Clinical trial
Randomized, Double Blind, Placebo Controlled, Multicenter Pilot Study on the Effects of Empagliflozin on Clinical Outcomes in Patients With Acute Decompensated Heart Failure (EMPA-RESPONSE-AHF)
NCT03200860 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Double Blind, Placebo Controlled, Multicenter Pilot Study on the Effects of Empagliflozin on Clinical Outcomes in Patients With Acute Decompensated Heart Failure (EMPA-RESPONSE-AHF)
- Lead sponsor
- University Medical Center Groningen
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 18, 2017
- Completion date
- September 18, 2019
- Enrollment
- 80 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure acute, heart failure; with decompensation, heart failure，congestive